Fasting review explores prostate cancer signaling with clinical questions still open
The abstract describes laboratory changes in hormone-receptor activity and treatment sensitivity, while leaving clinical benefits and risks unresolved for patients.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review connects intermittent fasting with changes in androgen receptor signaling, a pathway involved in prostate cancer growth and treatment resistance. The specific findings about improved treatment sensitivity come from preclinical research. The abstract does not demonstrate better survival, tumor control or quality of life in patients, and it flags possible loss of lean body mass.
The abstract provides no clinical sample sizes, treatment comparisons, effect estimates or follow-up periods. This limits assessment of whether the proposed mechanisms translate into meaningful benefits, or how often lean mass loss occurs.
What the laboratory findings suggest
Preclinical studies suggested reduced receptor expression, altered movement of the receptor into the cell nucleus and greater sensitivity to hormone-targeted treatments. These findings describe activity in research models; their importance for patient outcomes requires clinical testing.
Why clinical context matters
The authors suggest that effects may vary with the fasting pattern, energy intake, nutrient composition and the patient's metabolic context. They call for clinical studies that monitor biological markers and body composition alongside investigations of treatment response.
The original publication
Intermittent Fasting and Androgen Receptor Signaling in Prostate Cancer: Metabolic Crosstalk and Therapeutic Implications.
Gromadzka G, Bendykowska M
Int J Mol Sci · 2026
- PubMed ID
- 41898513
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.